(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.07%) $82.57
(1.77%) $2.07
(-0.70%) $2 341.30
(-1.57%) $27.23
(-0.33%) $958.30
(0.20%) $0.934
(0.32%) $11.02
(0.15%) $0.797
(0.01%) $93.31
Live Chart Being Loaded With Signals
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others...
Stats | |
---|---|
Dagens volum | 465.00 |
Gjennomsnittsvolum | 493 725 |
Markedsverdi | 0.00 |
Last Dividend | $0.108 ( 2022-03-30 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.819 (4.55%) |
Volum Korrelasjon
Olympus Corporation Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Olympus Corporation Korrelasjon - Valuta/Råvare
Olympus Corporation Økonomi
Annual | 2022 |
Omsetning: | $868.87B |
Bruttogevinst: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2022 |
Omsetning: | $868.87B |
Bruttogevinst: | $571.70B (65.80 %) |
EPS: | $90.35 |
FY | 2021 |
Omsetning: | $730.54B |
Bruttogevinst: | $459.53B (62.90 %) |
EPS: | $10.05 |
FY | 2020 |
Omsetning: | $797.41B |
Bruttogevinst: | $499.57B (62.65 %) |
EPS: | $39.37 |
Financial Reports:
No articles found.
Olympus Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0156 | 2003-03-26 |
Last Dividend | $0.108 | 2022-03-30 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | $1.329 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.62 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.84 | |
Div. Directional Score | 7.24 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
MUEL | Ex Dividend Junior | 2023-08-28 | Sporadic | 0 | 0.00% | |
CNTHP | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
SWRAY | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
HNFSA | Ex Dividend Junior | 2023-08-09 | Quarterly | 0 | 0.00% | |
ATDRY | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
OSCUF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
DQJCF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
TSGTY | Ex Dividend Knight | 2023-06-23 | Annually | 0 | 0.00% | |
JDVB | Ex Dividend Knight | 2023-07-27 | Quarterly | 0 | 0.00% | |
BMBN | Ex Dividend Knight | 2023-06-30 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.173 | 1.500 | 6.54 | 9.81 | [0 - 0.5] |
returnOnAssetsTTM | 0.0558 | 1.200 | 8.14 | 9.77 | [0 - 0.3] |
returnOnEquityTTM | 0.125 | 1.500 | 9.73 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.83 | 3.86 | [1 - 3] |
quickRatioTTM | 0.544 | 0.800 | -1.503 | -1.203 | [0.8 - 2.5] |
cashRatioTTM | 0.495 | 1.500 | 8.36 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.253 | -1.500 | 5.78 | -8.67 | [0 - 0.6] |
interestCoverageTTM | 35.39 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.584 | -1.500 | 7.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.686 | 1.000 | 1.908 | 1.908 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.236 | 1.000 | 7.28 | 7.28 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.232 | 1.000 | 9.82 | 9.82 | [0.2 - 2] |
assetTurnoverTTM | 0.323 | 0.800 | -1.183 | -0.946 | [0.5 - 2] |
Total Score | 10.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 46.41 | 1.000 | 5.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.125 | 2.50 | 9.82 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 34.81 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 64.44 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.000360 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.182 | 1.000 | 7.95 | 0 | [0.1 - 0.5] |
Total Score | 3.84 |
Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.